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Background: TNF-α is an inflammatory cytokine that plays an important role in insulin resistance observed in
obesity and chronic inflammation. Many cellular components involved in insulin signaling cascade are known to be
inhibited by TNF-α. Insulin receptor substrate (IRS)-1 is one of the major targets in TNF-α-induced insulin resistance.
The serine phosphorylation of IRS-1 enables the inhibition of insulin signaling. Until now, many studies have been
conducted to investigate the mechanism of TNF-α-induced insulin resistance based on Western blot. Intracellular
protein kinase crosstalk is commonly encountered in inflammation-associated insulin resistance. The crosstalk
among the signaling molecules obscures the precise role of kinases in insulin resistance. We have developed a cell
lysis-free quantum dots (QDots) multicolor cellular imaging to identify the biochemical role of multiple kinases (p38,
JNK, IKKβ, IRS1ser, IRS1tyr, GSK3β, and FOXO1) in inflammation-associated insulin resistance pathway with a single
assay in one run. QDot-antibody conjugates were used as nanoprobes to simultaneously monitor the activation/
deactivation of the above seven intracellular kinases in HepG2 cells. The effect of the test compounds on the
suppression of TNF-α-induced insulin resistance was validated through kinase monitoring. Aspirin, indomethacin,
cinnamic acid, and amygdalin were tested.
Results: Through the measurement of the glycogen level in HepG2 cell treated with TNF-α, it was found that aspirin
and indomethacin increased glycogen levels by almost two-fold compared to amygdalin and cinnamic acid. The
glucose production assay proved that cinnamic acid was much more efficient in suppressing glucose production,
compared with MAP kinase inhibitors and non-steroidal anti-inflammatory drugs. QDot multicolor cellular imaging
demonstrated that amygdalin and cinnamic acid selectively acted via the JNK1-dependent pathway to suppress the
inflammation-induced insulin resistance and improve insulin sensitivity.
Conclusion: The regulatory function of multiple kinases could be monitored concurrently at the cellular level. The
developed cellular imaging assay provides a unique platform for the understanding of inflammation and insulin
resistance signaling pathways in type II diabetes mellitus and how they regulate each other. The results showed that
amygdalin and cinnamic acid inhibit serine phosphorylation of IRS-1 through targeting JNK serine kinase and enhance
insulin sensitivity.
Keywords: Multicolor cellular imaging, Insulin resistance, Quantum dot, Inflammation* Correspondence: jmsong@snu.ac.kr
College of Pharmacy, Seoul National University, Seoul 151-742, South Korea
© 2015 Kim et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Kim et al. Journal of Nanobiotechnology  (2015) 13:4 Page 2 of 10Background
The worldwide prevalence of diabetes has progressively
risen over the past 30 years. According to the World Health
Organization, the global number of people with diabetes
is 371 million; of this population, around 90% suffer from
type II diabetes [1]. Cardiovascular disease, obesity, kidney
failure, diabetic retinopathy, and neuropathy are associ-
ated with type II diabetes mellitus (T2DM). Inflammation
and insulin resistance play a vital role in the above T2DM-
related diseases.
Perturbations in downstream proteins involved in in-
sulin signaling pathways have been found in insulin re-
sistance and inflammation-associated T2DM. Hundreds
of protein molecules are intricately involved in the insu-
lin signaling pathway. The insulin receptor substrate
(IRS1-4) proteins, phosphatidylinositol 3 kinase (PI3K),
and AKT/protein kinase B (PKB) are considered as the
best junctions for potential crosstalk with other pathways
[2]. IRS protein undergoes serine phosphorylation in re-
sponse to such stimuli as TNF-α and negatively controls
IRS signaling. In insulin-resistant states, the phosphoryl-
ation of IRS1 is elevated, and it activates many downstream
kinases, such as extracellular signal-regulated kinase ERK,
S6 kinase, and c-Jun-N-terminal kinase. TNF-α also func-
tions through its receptor on the cell surface and targets
multiple components, including the insulin receptor, the
insulin receptor substrate (IRS), glucose synthesis through
GSK3, gluconeogenesis via FOXO1, and glucose trans-
porter 4 (Glut4) in insulin-signal transduction [3]. On the
other hand, TNF-α is considered as one of the molecular
targets for suppressing inflammation in insulin-resistant
conditions. TNF-α induces the TAK kinase-IKKβ/p38/JNK
kinase axis and finally promotes PPAR γ inhibition [4].
Common protein kinases located in the signaling cascade
are responsible for crosstalk. In the case of inflammation-
associated insulin resistance, there are several instances
of crosstalk between insulin signaling composed of
IRS1-4 proteins, PI3K, AKT/protein kinase B (PKB), and
mitogen-activated protein kinases (MAPKs, i.e., p38, JNK,
and IKKβ) of inflammatory signaling. The crosstalk inter-
communication between the inflammation and insulin-
resistant kinases complicates our understanding of signal
propagation. Crosstalk creates a barrier to deciphering
the biochemical function of individual protein kinases in
metabolic disturbances. Consequently, inflammation-
associated T2DM disease mechanisms are poorly under-
stood. One of the most daunting challenges is to identify
the function of individual signaling molecules in the pres-
ence of two disease conditions, such as inflammation and
insulin resistance.
Until now, Western blot has been used as the main
tool to monitor signaling transductions which lead to in-
sulin resistance. The current approaches to evaluate sig-
naling molecule activity are deficient in terms of sensingphosphorylated proteins, tracing the junctions of cross-
talk, sensing variation in intensity level, and detecting
morphological changes in cells, specifically to identify in-
dividual protein molecules in a cell population. More-
over, the current approaches are qualitative in nature.
The quantification of the amount of specific proteins
can be difficult. Pure acquisition of a particular protein
from a pool of various proteins is not easy. Antibodies
may exhibit some off-target binding, which can cause
poor results. Performing a Western blot properly with
good results can be challenging, and requires a well-
trained staff. Moreover, during the entire procedure, the
temperature and pH must be maintained properly. Loss
of protein during the preparation of samples through
many experimental steps, including cell lysis, is also pos-
sible. As a result, large numbers of cells are needed due
to the degree of cell lysis. In spite of the large number of
cells to be lysed, insensitivity of Western blot makes it
difficult to correctly define activation or deactivation of
the relevant proteins. In this work, cell lysis-free multi-
color cellular imaging-based mechanism study for TNF-
α-induced insulin resistance is introduced. Proteins
involved in inflammation and insulin signaling were con-
currently monitored without cell lysis. This approach is
based on the use of quantum dot-antibody conjugates as
nanoprobes for simultaneously observing relevant pro-
teins. The nanoprobe can penetrate into the cellular mem-
brane without cell lysis and bind to the target protein via
its antibody. Several antibodies are capable of being at-
tached to the surface of quantum dot by covalently bond-
ing to 4-(maleimidomethyl)-1-cyclohexanecarboxylic acid
N-hydroxysuccinimide ester (SMCC) compound. QDdots
have superior optical properties, such as photostability, a
high level of brightness, and a higher photobleaching
threshold [5] than that of the organic dyes used in classic
immunofluorescence. In fact, QDdots are 10–20 times
brighter and have several thousand times more photo-
bleaching resistance than organic dyes [6]. Additionally,
QDots can be excited simultaneously at a particular
excitation wavelength compared to organic dyes [7].
This property enables multicolor cellular imaging for sim-
ultaneous monitoring of many relevant proteins involved
in TNF-α-induced insulin resistance. Biofunctionalized
QDots have been actively used as optical probes for cell
imaging. CdSe/ZnS QDots modified with dentate-like
alkyl chains and multiple carboxyl groups were developed
and conjugated with BRCAA1 and Her2 antibody. The
QDots were used for in vitro MGC803 cell labeling and
in vivo targeted imaging of gastric cancer cells [8]. A
hydrophilic semiconductor quantum dot-peptide forster
resonance energy transfer nanosensor was fabricated to
monitor the activity of kallikrein, a key proteolytic enzyme
functioning at the initiation of the blood clotting cascade
[9]. Avian influenza H5N1 pseudotype virus (H5N1p) was
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istry. The prepared QDot-H5N1ps were used to visualize
respiratory viral infections in mouse lung tissue in real-
time [10]. QDot-tagged photonic crystal beads were
successfully applied to the multiplex immunoassay of
tumor markers [11]. Compared to Western blot, the
present method consumes a much smaller number of cells
because of the direct monitoring of proteins in the cytosol
without cell lysis. First of all, direct monitoring of target
proteins without lysis definitely increases the accuracy of
the validations regarding the efficacy of test compounds
for suppression of inflammatory signaling and enhance-
ment of insulin signaling. High intensity, as well as lack of
protein loss, leads to enhancement of accuracy level. As a
result, the readouts are a closer reflection of physiological
intracellular protein expression. Moreover, multicolor cel-
lular imaging is more similar to in vivo results than bio-
chemical assays, resulting in reducing failures in clinical
trials. The entire procedure can be carried out faster than
Western blot. In addition, more than one protein is easily
monitored through a set of samples simultaneously. We
have undertaken a quantitative approach and computa-
tional methodology to identify the components of two sig-
naling pathways at the same time. Multicolor cellular
imaging acts as a catalyst for the rational targeting of spe-
cific kinases, mainly focusing on their functional role in
disease mechanisms. This assay can be considered as a
fundamental tool for concurrently defining the biochem-
ical functions of multiple kinases in multiple signaling
pathways with a single assay in one run.Figure 1 Effect of four different chemicals on inflammation-associate
was developed for various key kinases involved in inflammation-associated
and anti-inflammatory drugs as shown. The p38α, JNK1, and IKKβ involved in
associated with the insulin signaling pathway were simultaneously monHerein, we propose a new set of multicolor cellular im-
aging to study biochemical cell-signaling networks which
are convoluted, and contain different points of regulation,
signal divergence, and crosstalk with other transduction
pathways. Amygdalin and cinnamic acid were examined
to elucidate their molecular mechanism on the suppres-
sion of TNF-α-induced insulin resistance using multicolor
cellular imaging based on QDot nanoprobe. Seven kinases
were monitored in HepG2 cells treated with TNF-α for
the concurrent monitoring of inflammatory and insulin
signaling. Serine kinases, such as JNK, IKK, and p38α
were observed to verify their roles on serine phosphoryl-
ation of IRS-1. Furthermore, GSK3 and FOXO1 were
monitored as target proteins for the enhancement of
glycogen synthesis and suppression of gluconeogenesis in-
duced by amygdalin and cinnamic acid.
Results and discussion
Figure 1 shows a schematic model for TNF-α-induced insu-
lin resistance. TNF-α is the most extensively studied cyto-
kine from the point of view of insulin resistance. TNF-α
acts by direct and indirect mechanisms to converge at
multiple signaling nodes in the way of insulin action. Dir-
ect mechanisms include the stimulation of the serine
phosphorylation of IRS-1 and decreasing the expression
of IRS-1 and GLUT-4 [12]. Indirectly, TNF-α also inter-
acts with muscle cells, liver cells, and adipose tissue to
evoke insulin resistance. These stimuli may activate over-
lapping signal pathways via common upstream kinases in
the insulin pathway, such as IRS1-4 proteins, PI3K andd insulin signaling pathway in HepG2 cells. The QDot HCS assay
IR that are indicated with a red arrow and validated by specific inhibitors
the inflammatory pathway and IRS1ser307, IRS1tyr, FOXO1, and GSK3β
itored by QDot multicolor cellular imaging.
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kinases, such as p38α, JNK1, and IKKβ in inflammatory
signaling. The crosstalk between inflammation and insulin
signaling is a major hurdle for understanding the molecu-
lar link between the two pathways. The present ap-
proaches to studying cellular signaling mechanisms suffer
from fluctuation in the activities of intracellular kinases
and reproducible results. Therefore, we developed a novel
QDot-based quantitative multicolor cellular imaging for
simultaneous analysis and monitoring of the activity of
various kinases in both disease mechanisms. As shown in
Figure 2(a), the phospho-p38α, phospho-JNK1, phospho-
IKKβ, phospho-IRS1ser307, phospho-IRS1tyr, phospho-
GSK3β, and phospho-FOXO1 antibodies were conjugated
with 565, 565, 565, 605, 705, 525, and 655 QDots, respect-
ively, using an antibody conjugation kit for deciphering
the insulin resistance pathway. The conjugate between
QDot and antibody was verified through a dynamic light
scattering and zeta potential measurement. Figure 2(b) and
(c) show particle sizes of QDot605 and QDot605-antibody
conjugate measured with dynamic light scattering. As a re-
sult of conjugation, the size of QDot605-antibody conju-
gate increased compared to QDot605. Table 1 summarizesFigure 2 Characterization of QDot-antibody conjugates. (a). A schema
Particle size analysis of QDot605 and QDot605-antibody conjugate obtaine
executed using Photal ELSZ-1000 instrument (Otsuka Electronics Ltd., O
QDot605-antibody conjugates were diluted with 0.22 μm filtered water
for QDot605-antibody conjugate by particle size analysis. (d). Emission spectraparticle sizes and zeta potential values of QDots and
QDot-antibody conjugates used in this study. Antibodies
conjugated to QDots have different structures and charges.
As a result, the size of QDot-antibody conjugate was not
proportional linearly to that of QDot. Zeta potential values
of QDot-antibody conjugates were larger than those of
QDots due to the conjugation between QDot and anti-
body. Zeta potential values of QDot-antibody conjugates
were hardly changed three weeks after the conjugation.
Emission spectra of five different QDots are very narrow
(Figure 2[d]), which is appropriate for the elimination
of crosstalk in high-content cell-based assay. In addition,
acousto-optic tunable filter (AOTF) can contribute greatly
to the spectral overlap-free high-content monitoring. AOTF
allows cellular imaging at particular single wavelengths
devoid of spectral overlap among QDot-antibody con-
jugates. The crosstalk-free high-content monitoring
of inflammation and insulin signal transduction was
attempted using QDot-antibody conjugates and AOTF
in this work. We investigated the effect of various in-
flammatory kinase inhibitors acting on insulin signaling
and evaluated the compound efficacies for the functional
ability to inhibit gluconeogenesis and enhance glycogentic diagram of QDot-antibody conjugation mediated with SMCC. (b,c).
d through dynamic light scattering. Particle size measurements were
saka, Japan). Before the particle size measurements, QDot605 and
. Average diameter calculated was 11.12 nm for QDot605 and 20.4 nm
of QDot525, QDot565, QDot 605, QDot655, and QDot705.
Table 1 Summary of particle sizes and zeta potential





QDot525 antibody conjugate 15.16 −13.5
QDot565 10.3 −2.4
QDot565 antibody conjugate 20.3 −11.98
QDot605 13.7 −3.72
QDot605 antibody conjugate 16.1 −16.65
QDot655 15.9 −4.5
QDot655 antibody conjugate 20.4 −17.6
QDot705 17.1 −5.54
QDot705 antibody conjugate 23.2 −18.7
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suppressing inflammation-induced insulin resistance. Our
experiment also addresses the suitability of multicolor
cellular imaging for studying kinase crosstalk operating
in complex diseases, such as inflammation-associated
insulin resistance, at a single shot in a single cell. Surpris-
ingly, amygdalin and cinnamic acid acted selectively via the
JNK1-dependent pathway to improve insulin sensitivity.
The HepG2 cell line was chosen for this study as it is a per-
petual, epithelial cell line derived from well-differentiated
hepatocellular carcinoma. These cells solely depend upon
exogenous growth factors for survival and respond to stim-
uli, such as TNF-α, adiponectin, leptin, etc. To study the
causal role of elevated cytokines levels and MAP kinase
inhibitors in hepatic insulin resistance, HepG2 cells were
treated with inhibitors 30 min prior to stimulation with
10 ng/ml TNF-α for 5 h. The cells were then treated with
100 nM insulin for 10 min. Past studies using the obeseFigure 3 Quantification of glycogen and glucose production in HepG2 he
HepG2 hepatocytes in the presence of TNF-α. Human HepG2 hepatocytes we
were added 30 min before stimulation with 10 ng/ml TNF-α. After 5 h, the ce
carried out according to the manufacturer’s instructions (Biovision, Milpitas, C
inhibitors on glucose production. All values are mean ± SD, n = 3.TNF-α+/+ mice model have shown disturbances in insulin
signaling in response to TNF-α [13]. Therapies that have
successfully targeted TNF-α, including genetic silencing of
the TNF-α or TNF receptor in mice, have demonstrated
significant efficacy in the treatment of obesity-related
insulin resistance. Therefore, we established the insulin re-
sistance model in vitro using TNF-α stimulation of HepG2
cells. The glycogen amount decreased in the TNF-α treated
group, suggesting compromised insulin sensitivity. The
MAP kinase inhibitors suppressed the effect of TNF-α
on the insulin transduction pathway and consequently
resulted in elevated levels of glycogen content (Figure 3a).
The inflammatory signaling inhibitors, such as p38α
kinase inhibitors (SB203580), JNK1 inhibitors (SP600125),
IKKβ inhibitors, aspirin, and indomethacin increased glyco-
gen levels by almost two-fold in comparison to amygdalin
and cinnamic acid. Glycogen content in HepG2 cells
treated with p38, JNK1, IKKβ inhibitors, aspirin, and indo-
methacin were four to five times higher than that of the
control; whereas, glycogen content in amygdalin or cin-
namic acid-treated HepG2 cells were two to three times
higher than that of the control [14]. As shown by a
glucose production assay, exposure of HepG2 cells to in-
hibitors reduced gluconeogenesis in comparison to the
control group (Figure 3b). Cinnamic acid was much more
potent in suppressing glucose production than MAP kin-
ase inhibitors and non-steroidal anti-inflammatory drugs.
The rate of hepatic glucose production by amygdalin was
similar to that of aspirin.
Crosstalk among the common signaling molecules com-
plicates our understanding of the relation between in-
flammation and insulin resistance. Our next goal was to
develop novel QDot-based multicolor cellular imaging for
simultaneous monitoring of inflammatory and insulin
signaling pathway kinases. For the first time, the QDotpatocytes. (a). Enhancement of glycogen content in inhibitor-pretreated
re plated in serum-free DMEM media for 24 h prior to testing. Inhibitors
lls were treated with 100 nM insulin for 10 min, and further steps were
A, USA). All values are mean ± SD, n = 3. (b). The effect of MAP kinase
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induced insulin resistance using the quantitative multi-
color cellular imaging. The insulin signaling and one of
three inflammatory MAP kinases (p38α, JNK1, and IKKβ)
were simultaneously observed. Selective binding of QDot-
antibody conjugates to targeted proteins is essential for
the successful observation of intracellular signal transduc-
tion related to TNF-α-induced insulin resistance. This
novel assay is quite useful in tracing kinases without mor-
phological changes in the cell being investigated. The in-
flammatory pathways via MAP kinases (p38α, JNK1, and
IKKβ) were not activated in the negative control group
free of any TNF-α stimulation, as shown in Figure 4. In
the positive control group, the HepG2 cells were treatedFigure 4 High-content cellular images of kinases. (a,b,c). Multicolor cel
downregulation of five kinases in HepG2 cells. Five kinases: p-GSK3β, p-p38
was stimulated with TNF-α; whereas, in the negative control, TNF-α treatm
serum-free DMEM media for 24 h prior to testing. P38 inhibitor was added
were treated with 100 nM insulin. The cells were treated with formaldehy
saponin. The QDot-antibody conjugate (p-p38α, p-JNK1, p-IKKβ, p-IRS1se
estimation and monitoring of the phosphorylation of the five kinases were sim
in the experimental section. 1: Positive Control, 2: Negative Control, 3: p38 inh
Amygdalin treatment, 7: Cinnamic acid treatment. (b) 1: Positive Control, 2: N
Indomethacin treatment, 6: Amygdalin treatment, 7: Cinnamic acid trea
4: Aspirin treatment, 5: Indomethacin treatment, 6: Amygdalin treatmen
treated with non-conjugated QDots (QDot525, QDot565, QDot605, QDot6
of seven different kinases in HepG2 cells. TNF-α induction was absent in the n
TNF-α. AS: Aspirin, IM: Indomethacin, AD: Amygdalin, CA: Cinnamic acidwith TNF-α to mimic the inflammation-induced insulin-
resistant conditions. TNF-α stimulated the phosphoryl-
ation of MAP kinases (p38α, JNK1, and IKKβ) and IRS1-
ser307, and inhibited insulin downstream kinases (GSK3β,
FOXO1, and IRS1tyr) (Figure 4).
To further elucidate the role of p38α in relation to
insulin resistance, we tested insulin signaling kinases,
such as GSK3β, FOXO1, IRS1ser307, and IRS1tyr in TNF-α-
stimulated HepG2 cells pretreated with a 5 μM p38-specific
inhibitor SB203580 for 30 min. As shown in Figure 4a,
TNF-α-stimulated HepG2 cells show the phosphorylation
of p38α along with IRS1ser307 in comparison to the nega-
tive control group. The SB203580 inhibitor suppressed the
activation of p38α and IRS1ser307; whereas, the activatedlular imaging showing simultaneous monitoring of the upregulation/
α, p-IRS1ser307, p-FOXO1, and p-IRS1tyr. (a) The positive control group
ent was absent. For inhibitor studies, HepG2 cells were plated in
30 min before stimulation with 10 ng/ml TNF-α (for 5 h), and the cells
de for fixing the cells following permeability enhancement using
r, p-IRS1tyr, p-GSK3β, and p-FOXO1) treatment was done. Quantitative
ultaneously carried out according to emission wavelengths mentioned
ibitor (SB203580), 4: Aspirin treatment, 5: Indomethacin treatment, 6:
egative Control, 3: JNK-1 inhibitor (SP600125), 4: Aspirin treatment, 5:
tment. (c) 1: Positive Control, 2: Negative Control, 3: IKKβ inhibitor,
t, 7: Cinnamic acid treatment. (d) Cellular images of HepG2 cells
55, QDot705). (e) Western blot analysis of upregulation/downregulation
egative control (NC). The positive control (PC) was stimulated with
.
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were similar to those of the negative control group and
had a favorable effect on insulin sensitivity, similar to pre-
vious studies using Western blot [15]. To explore the ap-
plication of the developed assay for pathway studies, we
further screened the activities of NSAIDs, such as aspirin
and indomethacin, along with two herbal active constitu-
ents, such as amygdalin and cinnamic acid. The above
four molecules have not been shown to inhibit the p38
inflammatory pathway, but they still inhibited the phos-
phorylation of IRS1ser307 responsible for insulin resistance
by acting through other signaling kinases (Figure 4a). We
next investigated whether these four molecules can act
via the JNK1 pathway. The experimental conditions were
similar to those of the p38 screening, except for the
use of specific JNK inhibitor SP600125 (4 μM). Positive-
controlled HepG2 cells cause activation of IRS1ser307 by
the JNK1 pathway (Figure 4b). The JNK1-specific inhibitor
completely inhibited the phosphorylation of JNK1 and
IRS1ser307. The four inhibitor molecules inhibited the
JNK1 pathway to almost the same extent and enhanced
insulin sensitivity, as shown in the restored extent of phos-
phorylation of GSK3β, FOXO1, and IRS1tyr (Figure 5b).
There are several reports of the hypoglycemic effects of
naturally-derived active components which have anti-
inflammatory activity, such as phenolic acid (cinnamic
acid) and cyanogenic glycosides amygdalin. The cellular
and molecular mechanism of action of cinnamic acid and
amygdalin has not been well elucidated in conditions
mimicking inflammation-associated insulin resistance. Al-
though cinnamic acid and amygdalin were expected to act
through inhibition of the IKKβ and NF-κB pathway, they
acted via the JNK1-dependent pathway to improve insulin
sensitivity. Our results are congruent with past studiesFigure 5 Quantitative analysis of Figure 4(a,b,c). (a, b, c). The fluoresce
p-IRS1tyr) and each of p38, JNK1, IKKβ, and inhibitor-treated HepG2 cells we
and c. The fluorescence intensities were calculated as described in Methodconducted on mouse liver FL83B cells using phenolic acid,
such as cinnamic acid. Cinnamic acid up-regulates the
expression of insulin signal associated proteins, including
phosphatidylinositol-3 kinase, glycogen synthase, and in-
sulin receptor; it also increases the uptake of glucose, and
abates insulin resistance [16]. Our results agree with the
JNK1 pathway studies conducted on hepatocytes and
mouse liver cells [17]. Finally, we used the specific IKKβ
inhibitor (2 μM) to find the relation to the insulin signaling.
The IKKβ inhibitor also inhibited IRS1ser307 via suppression
of IKKβ kinase. Among the four molecules, aspirin sub-
stantially inhibited IKKβ kinase activation followed by
indomethacin; whereas, amygdalin and cinnamic acid
showed moderate inhibition (Figures 4c and 5c). Figure 4e
is a Western blot analysis to show suppression of TNF-α-
induced insulin resistance induced by the four test mole-
cules. Activations/deactivations of seven different kinases
were observed to compare the results obtained with QDot
multicolor cellular imaging. Although detection sensi-
tivity of Western blot is poorer than that of QDot multi-
color cellular imaging, the results by Western blot were
matched with those by QDot multicolor cellular imaging.
Figure 5 represents the quantification of cellular images in
Figure 4. Our results are in line with past studies support-
ing the major role of IKKβ in insulin resistance [18].
In insulin resistance-free conditions, insulin phosphor-
ylates Forkhead box-containing O subfamily-1(FOXO1),
resulting in the inhibition of transcriptional activity,
leading to reduced glucose production. Moreover, insulin
phosphorylates GSK-3, thereby leading to an increase in
glycogen synthase activity. The glycogen synthesis is con-
trolled by glycogen synthase kinase-3 (GSK-3). On the
other hand, TNF-α stimulation inhibits the phosphoryl-
ation of FOXO1 kinase and increases glucose production.nce intensities of the four kinases (p-GSK3β, p-IRS1ser307, p-FOXO1, and
re normalized to the control, respectively, as shown in Figure 4a, b,
s.
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nents involved in insulin signaling cascade. Insulin receptor,
IRS, and glucose transporter 4 (Glut4) are representative
proteins to be inhibited by TNF-α. Particularly, IRS has re-
ceived great attention as a major target in TNF-α-induced
insulin resistance. Insulin signaling is suppressed by an in-
crease of serine phosphorylation of IRS proteins caused by
TNF-α. A few mechanisms have been reported to be in-
volved in serine phosphorylation of IRS proteins, such as
inhibition of tyrosyl phosphorylation of IRS-1 [19] and
proteasome-mediated degradation of IRS-1 [20]. Inter-
action between insulin receptor and IRS-1 is interfered by
the inhibition of tyrosyl phosphorylation of IRS-1; as
a result, IRS-mediated insulin signaling is suppressed.
Serine phosphorylation of IRS-1 by TNF-α can be achieved
through activation of several serine kinases, including ki-
nases related to the inflammatory pathway, such as JNK.
The suppression of IRS-mediated insulin signaling leads to
reduced GSK-3 and FOXO1 phosphorylation, followed by
decreased glycogen synthesis and increased gluconeogene-
sis. Our results showed that cinnamic acid and amygdalin
enhanced the phosphorylation level of GSK-3 and FOXO1.
As a result, glycogen synthesis was increased and glucose
production was reduced.Conclusion
The above results corroborate that QDot multicolor cel-
lular imaging can be applied to investigate the molecular
pathogenesis and inhibitor studies of multiple signaling
pathways (i.e., insulin signaling and the inflammatory
pathway) which share common intracellular proteins.
Compared to Western blot, QDot multicolor cellular
imaging enabled direct and concurrent accesses to intra-
cellular target proteins related to TNF-α-induced insulin
resistance. The designed monitoring proved that cell lysis-
free QDot multicolor cellular imaging was a powerful tool
for identifying novel molecular targets for suppressing
inflammation in insulin resistance. The developed assay
successfully verified that cinnamic acid and amygdalin sup-
pressed TNF-α-induced insulin resistance mainly via the in-
hibition of JNK.Methods
Materials
General chemicals, including a glucose assay kit and
TNF-α, were obtained from Sigma-Aldrich (St. Louis,
MO, USA) and were of the highest purity available. The
glycogen assay kit was purchased from BioVision (Milpitas,
CA, USA). The phospho-p38α, phospho-JNK1, phospho-
IKKβ, phospho-IRS1ser307, phospho-IRS1tyr, phospho-
GSK3β, and phospho-FOXO1 antibodies were obtained
from Santa Cruz Biotechnology (Dallas, TX, USA) and
conjugated with 565, 565, 605, 705, 525, and 655 QDots,respectively, using an antibody conjugation kit from
Invitrogen (Carlsbad, CA, USA).
Cell culture
HepG2 cells were obtained from the Korean Cell Line
Bank (Seoul, South Korea) and cultured in Dulbecco's
modified Eagle's medium supplemented with 10% fetal bo-
vine serum, 100 μg/ml penicillin, and 100 μg/ml strepto-
mycin. All of the cells were cultured in 25 cm2 cell culture
flasks at 37°C in a humidified atmosphere of 5% CO2.
For inhibitor studies, HepG2 cells were plated in serum-
free DMEM media for 24 h prior to testing. Inhibitors were
added 30 min before stimulation with 10ng/ml TNF-α.
After 5-h stimulation with TNF-α, the cells were treated
with 100 nM insulin for 10 min.
Analysis of glycogen content
Glycogen content in various inhibitor-treated HepG2 cells
was measured with a glycogen assay kit according to the
manufacturer’s instructions.
Glucose production assay
Cells were washed three times with PBS to remove glu-
cose, incubated for 16 h in 1 ml of glucose production
medium (glucose and phenol red-free DMEM, containing
gluconeogenic substrates, 20 mm sodium lactate, and 2
mm sodium pyruvate), and in the presence of 1 nm insu-
lin during the last 3 h. 300 μl of the medium was sampled
for the measurement of glucose concentration using a glu-
cose assay kit.
QDot conjugation with specific antibody
The p38α, JNK1, IKKβ, IRS1ser307, IRS1tyr, GSK3β, and
FOXO1 antibodies were conjugated with 565, 565, 565,
605, 705, 525, and 655 QDots, respectively, using an
antibody conjugation kit. The used QDots are semicon-
ductor materials that consisted of core, shell, and poly-
meric coating. The core is made up of cadmium selenide
and passivated with zinc sulfide as the shell. The QDot
composed of core-shell is highly hydrophobic. In order
to enhance water solubility and conjugate efficiently to
biomolecules, QDots surfaces were modified with the
amine-functionalized polyethylene glycol (PEG) linker.
Conjugation steps were carried out according to the man-
ufacturer's instructions. QDots were activated with SMCC
used as an amine-to-thiol crosslinker to the maleimide-
nanocrystal surface. To break the disulfide bond in anti-
bodies and to expose free sulfhydryls, the antibodies
were treated with dithiothreitol (DTT). Size exclusion
chromatography was performed to remove excess SMCC
and DTT. Maleimide-QDots were incubated with the re-
duced antibodies for 1 h. By this reaction, antibodies were
covalently bound to QDots. The excess maleimide groups
were removed by β-mercaptoethanol. A separation media
Kim et al. Journal of Nanobiotechnology  (2015) 13:4 Page 9 of 10column supplied in the kit was used to eliminate un-
bounded QDots and antibodies. The maximum emission
wavelengths of phospho-GSK3β, phospho-IKKβ, phospho-
p38α, phospho-JNK1, phospho-IRSSer307, phospho-FOXO1,
and phospho-IRStyr are 525, 565, 565, 565, 605, 655, and
705 nm, respectively.
QDot immunoassay using QDot multicolor cellular
imaging
HepG2 cells were separately seeded into 12 well culture
plates (5 × 105 cells/well). After 24 h, the cells were washed
twice with 1× phosphate-buffered saline (PBS), treated
with accutase and incubated at 37°C for 10–15 min. The
detached cells from the culture plates were centrifuged at
220 g for 3 min. After removing the supernatant, the cells
were treated with 3.7% formaldehyde for 15 min. The cells
were then rinsed twice with 1 × PBS and centrifuged at 220
g for 3 min. The cells were treated with 0.2% saponin for
15 min to increase the pore size of the cell membrane,
followed by washing twice with 1 × PBS and centrifugation
at 220 g for 3 min. After the QDot-antibody conjugate, its
concentration was determined to be 2 μM using an absorp-
tion spectrophotometer. QDot-antibody conjugates (p38α,
JNK1, IKKβ, IRS1ser, IRS1tyr, GSK3β, and FOXO1) were di-
luted (1/200) in 100 μl of blocking buffer (1% BSA in 1 ×
PBS). The HepG2 cell pellet was immersed in the diluted
QDot-antibody solution of 100 μl and kept for 1 h at room
temperature. The cells were then washed twice with 1 ×
PBS and centrifuged at 220 g for 3 min. Intracellular moni-
toring of the five different kinases were simultaneously car-
ried out at 525 nm, 565 nm, 625 nm, 655 nm, and 705 nm
emission wavelengths to observe their phosphorylations in-
duced by tested drugs [21-23]. The fixed cell formed by
formaldehyde treatment is a kind of dead cell that main-
tains its morphology. The fixed dead HepG2 cells were
treated with Qdot-antibody probes for the immunostain-
ing. Accordingly, toxicity inherent to Qdots does not
affect drug-induced up-regulation or down-regulation of
intracellular target proteins. Imaging analysis was performed
using commercially available software (MetaMorph, Version
7.1.3.0, Molecular Devices, Sunnyvale, CA, USA).
Calculation of normalized intensity
Figure 5(a-c) shows the quantification of fluorescence in-
tensities in the cell images obtained with QDot multicolor
cellular imaging. Fluorescence intensities of p-GSK3β,
p-FOXO1, and p-IRStyr were normalized according to
the following equation:
Normalized Intensity ¼ Is=Inð Þ;
The fluorescence intensity of the inhibitor-treated cells
is represented by Is, and In represents the fluorescence
intensity of cells in the negative control group.The normalized fluorescent intensities of p-p38, p-JNK,
p-IKKβ, and p-IRSser307 were calculated according to the
following equation:
Normalized Intensity ¼ Is=Ip
 
;
The fluorescence intensity of the inhibitor-treated cells
is represented by Is, and Ip is the fluorescence intensity
of cells in the positive control. All of the intensities in
Figure 5 were the averaged value of cellular intensities ob-
tained from three different cellular regions. The standard
deviation was represented as the error bar in Figure 5.
Western blotting
HepG2 cells (1 × 106) were lysed using Lysis-M solution
(Roche, Manheim, Germany). Electrophoresis was per-
formed on 12% sodium dodecyl sulfate-polyacrylamide gel
(SDS-PAGE) by loading 60 μg of protein from HepG2
cells. The proteins were transferred to a polyvinylidene
difluoride (PVDF) membrane (BioRad, Hercules, CA,
USA) after the electrophoresis. Appropriate primary anti-
bodies were used for Western blot analysis. Membranes
were blocked overnight at 4°C in 1 × PBS, containing
0.05% TWEEN® 20 and 5% bovine serum albumin. Each
specific antibody at a dilution of 1:1,000 was used in the
Western blot analysis. Similarly, beta actin antibody at a
dilution of 1:1,000 was used for the detection of beta actin
(positive control). Primary antibodies were detected via a
secondary peroxidase-conjugated antibody at a dilution of
1:10,000 (Dako Ltd., High Wycombe, Bucks, UK). An en-
hanced chemiluminescence detection kit (Roche, Basel,
Switzerland) was used for signal detection.
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